These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38390617)

  • 1. Gut-Microbiome Implications in Opioid Use Disorder and Related Behaviors.
    Herlihy B; Roy S
    Adv Drug Alcohol Res; 2022; 2():10311. PubMed ID: 38390617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linking the gut microbiome to microglial activation in opioid use disorder.
    Antoine D; Venigalla G; Truitt B; Roy S
    Front Neurosci; 2022; 16():1050661. PubMed ID: 36590299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the gut microbiome in opioid use.
    Ren M; Lotfipour S
    Behav Pharmacol; 2020 Apr; 31(2&3):113-121. PubMed ID: 31895059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bidirectional relationship between opioids and the gut microbiome: Implications for opioid tolerance and clinical interventions.
    Taboun ZS; Sadeghi J
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111142. PubMed ID: 37918085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary Supplementation with Omega-3 Polyunsaturated Fatty Acids Reduces Opioid-Seeking Behaviors and Alters the Gut Microbiome.
    Hakimian JK; Dong TS; Barahona JA; Lagishetty V; Tiwari S; Azani D; Barrera M; Lee S; Severino AL; Mittal N; Cahill CM; Jacobs JP; Walwyn WM
    Nutrients; 2019 Aug; 11(8):. PubMed ID: 31416242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Gut Microbiome and Substance Use Disorder.
    Russell JT; Zhou Y; Weinstock GM; Bubier JA
    Front Neurosci; 2021; 15():725500. PubMed ID: 34531718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiome-Mediated Mechanisms in Alleviating Opioid Addiction with Aqueous Extract of
    Baslam A; Kabdy H; Chait Y; Azraida H; El Yazouli L; Aboufatima R; Chait A; Baslam M
    Biomedicines; 2024 May; 12(6):. PubMed ID: 38927359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Gut Microbiome in Autism: Study-Site Effects and Longitudinal Analysis of Behavior Change.
    Fouquier J; Moreno Huizar N; Donnelly J; Glickman C; Kang DW; Maldonado J; Jones RA; Johnson K; Adams JB; Krajmalnik-Brown R; Lozupone C
    mSystems; 2021 Apr; 6(2):. PubMed ID: 33824197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal microbiota transplantation and antibiotic treatment attenuate naloxone-precipitated opioid withdrawal in morphine-dependent mice.
    Thomaz AC; Iyer V; Woodward TJ; Hohmann AG
    Exp Neurol; 2021 Sep; 343():113787. PubMed ID: 34153321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid Use, Gut Dysbiosis, Inflammation, and the Nervous System.
    Jalodia R; Abu YF; Oppenheimer MR; Herlihy B; Meng J; Chupikova I; Tao J; Ghosh N; Dutta RK; Kolli U; Yan Y; Valdes E; Sharma M; Sharma U; Moidunny S; Roy S
    J Neuroimmune Pharmacol; 2022 Jun; 17(1-2):76-93. PubMed ID: 34993905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A potential role for the gut microbiome in substance use disorders.
    Meckel KR; Kiraly DD
    Psychopharmacology (Berl); 2019 May; 236(5):1513-1530. PubMed ID: 30982128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid trail: Tracking contributions to opioid use disorder from host genetics to the gut microbiome.
    Duffy EP; Bachtell RK; Ehringer MA
    Neurosci Biobehav Rev; 2024 Jan; 156():105487. PubMed ID: 38040073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-Like Peptide-1 Receptor Agonist Treatment Does Not Reduce Abuse-Related Effects of Opioid Drugs.
    Bornebusch AB; Fink-Jensen A; Wörtwein G; Seeley RJ; Thomsen M
    eNeuro; 2019; 6(2):. PubMed ID: 31058214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pain, Motivation, Migraine, and the Microbiome: New Frontiers for Opioid Systems and Disease.
    Parker KE; Sugiarto E; Taylor AMW; Pradhan AA; Al-Hasani R
    Mol Pharmacol; 2020 Oct; 98(4):433-444. PubMed ID: 32958571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioids and the hormone oxytocin.
    Kovatsi L; Nikolaou K
    Vitam Horm; 2019; 111():195-225. PubMed ID: 31421701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: Current understanding and approaches to management.
    Pergolizzi JV; Raffa RB; Rosenblatt MH
    J Clin Pharm Ther; 2020 Oct; 45(5):892-903. PubMed ID: 31986228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs and Bugs: The Gut-Brain Axis and Substance Use Disorders.
    Simpson S; Mclellan R; Wellmeyer E; Matalon F; George O
    J Neuroimmune Pharmacol; 2022 Jun; 17(1-2):33-61. PubMed ID: 34694571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in factors predicting post-treatment opioid use.
    Davis JP; Eddie D; Prindle J; Dworkin ER; Christie NC; Saba S; DiGuiseppi GT; Clapp JD; Kelly JF
    Addiction; 2021 Aug; 116(8):2116-2126. PubMed ID: 33405314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the gut microbiome and microbial metabolism in mediating opioid-induced changes in the epigenome.
    Kolli U; Roy S
    Front Microbiol; 2023; 14():1233194. PubMed ID: 37670983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gut microbiota mediates reward and sensory responses associated with regimen-selective morphine dependence.
    Lee K; Vuong HE; Nusbaum DJ; Hsiao EY; Evans CJ; Taylor AMW
    Neuropsychopharmacology; 2018 Dec; 43(13):2606-2614. PubMed ID: 30258112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.